Natural Health Trends Corp. — FY 2011 Form 10-K
Reporting period: Fiscal year ended December 31, 2011, compared with FY 2010. This filing does not provide clear stand-alone fourth-quarter results.
Business context
The company sells NHT Global wellness, skincare and lifestyle products through independent distributors and e-commerce. Its markets include Greater China, Russia, North America, South Korea, Japan and Europe. Hong Kong revenue includes substantial sales to members in China; the company does not have a Chinese direct-selling license and operates there through e-commerce models.
Financial results and liquidity
| Metric | FY 2010 | FY 2011 |
|---|---|---|
| Net sales | $23.576 million | $31.162 million |
| Gross profit / margin | $16.607 million / 70.4% | $22.990 million / 73.8% |
| Operating income (loss) | $(3.079) million | $1.783 million |
| Net income (loss) | $(2.469) million | $2.425 million |
| Net income (loss) attributable to common stockholders | $(2.464) million | $2.289 million, or $0.21 per share |
| Cash provided by (used in) operating activities | $(0.292) million | $1.463 million |
Sales increased about 32% year over year. Selling, general and administrative expense declined to $9.052 million from $9.802 million, while distributor commissions rose to 38.0% of sales from 36.8%. The 2011 income tax benefit was $298,000; the company said it did not recognize a U.S. tax benefit because realization was uncertain.
At year-end, cash and cash equivalents were $1.617 million, restricted cash was $714,000, current assets were $3.830 million and current liabilities were $6.932 million. The current ratio was 0.55:1, and the working-capital deficit was approximately $3.1 million (about $2.1 million excluding deferred revenue). Total liabilities were current liabilities; the balance sheet lists no long-term debt. Related-party advances were repaid during 2011. Stockholders’ deficit improved to $809,000 from $2.821 million.
Changes and notable items
- Hong Kong sales rose 51% to $21.038 million and represented 67.5% of revenue; Russia sales increased 28% to $4.537 million. Active distributors increased to 18,410 from 16,350.
- Gross margin improved with a Russia price increase, Hong Kong anniversary-event ticket sales and higher-margin product offerings, and lower Russian logistics fees.
- Operating results included a $477,000 benefit from settling vendor payables below their carrying value and a $65,000 gain on liquidation of a non-operating subsidiary. The Hong Kong 10th-anniversary event also contributed revenue and increased event expenses.
- Cash increased by $969,000 during the year. The company reported no goodwill or intangible-asset impairment; acquired software intangibles were fully amortized by year-end.
Outlook, risks and contingencies
Management expects cash on hand and operating cash flows to fund normal operations and commitments for at least 12 months, assuming no significant unforeseen expense or further revenue decline. It plans to focus resources on Greater China and Russia rather than materially opening new markets. No numerical revenue or earnings guidance is provided.
- China regulatory uncertainty is a central risk: the company lacks a direct-selling license, its application was withdrawn in 2009 and has not been refiled, and authorities could restrict its e-commerce activity or require changes to its model. Hong Kong concentration heightens this exposure.
- Product and supplier concentration: four major product lines account for a significant majority of sales, and products are sourced from independent manufacturers, including key suppliers without long-term contracts for some products.
- Liquidity remains constrained by the working-capital deficit and limited unused liquid resources. Management’s liquidity view depends on maintaining sales and controlling costs.
- Other risks include distributor retention and compensation costs, foreign-exchange movements, product and direct-selling regulation, and the absence of company product-liability insurance.
- At December 31, 2011, 3.705 million warrants were outstanding; some carry anti-dilution provisions. Preferred stock had $157,000 of accrued unpaid dividends, which were not declared and generally are not obligatory to pay.
- The company was considering a royalty and license arrangement with an entity in which director George Broady has an interest, relating to the Restor product; terms were not finalized. Previously disclosed litigation had been settled, and the filing states no litigation was pending.
The independent auditor gave an unqualified opinion on the financial statements. Management concluded internal control over financial reporting was effective; the auditor did not attest to that assessment.
Important facts for investors to verify
- Whether Hong Kong/China sales and distributor activity remain sustainable under changing Chinese regulatory interpretations.
- Cash generation, working-capital needs and whether the 12-month liquidity assumption holds if revenue weakens.
- Sales dependence on the four major products and the reliability and contractual terms of key suppliers.
- Distributor commission trends, the contribution and cost of promotions, and the sustainability of the 2011 margin recovery.
- Potential dilution from outstanding warrants and the final terms and governance review of any Broady-related Restor agreement.